- Home
- INGN vs CATX Comparison
INGN vs CATX Comparison
Compare INGN & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGN
- CATX
- Stock Information
- Founded
- INGN 2001
- CATX 1983
- Country
- INGN United States
- CATX United States
- Employees
- INGN N/A
- CATX N/A
- Industry
- INGN Industrial Specialties
- CATX Medical/Dental Instruments
- Sector
- INGN Health Care
- CATX Health Care
- Exchange
- INGN Nasdaq
- CATX Nasdaq
- Market Cap
- INGN 219.3M
- CATX 239.0M
- IPO Year
- INGN 2014
- CATX N/A
- Fundamental
- Price
- INGN $8.36
- CATX $3.37
- Analyst Decision
- INGN Strong Buy
- CATX Strong Buy
- Analyst Count
- INGN 3
- CATX 11
- Target Price
- INGN $11.00
- CATX $12.90
- AVG Volume (30 Days)
- INGN 244.2K
- CATX 703.2K
- Earning Date
- INGN 11-06-2025
- CATX 08-13-2025
- Dividend Yield
- INGN N/A
- CATX N/A
- EPS Growth
- INGN N/A
- CATX N/A
- EPS
- INGN N/A
- CATX N/A
- Revenue
- INGN $343,472,000.00
- CATX $1,235,000.00
- Revenue This Year
- INGN $7.68
- CATX N/A
- Revenue Next Year
- INGN $6.47
- CATX N/A
- P/E Ratio
- INGN N/A
- CATX N/A
- Revenue Growth
- INGN 5.15
- CATX N/A
- 52 Week Low
- INGN $5.70
- CATX $1.60
- 52 Week High
- INGN $12.91
- CATX $16.31
- Technical
- Relative Strength Index (RSI)
- INGN 68.46
- CATX 43.20
- Support Level
- INGN $7.72
- CATX $3.20
- Resistance Level
- INGN $8.18
- CATX $3.85
- Average True Range (ATR)
- INGN 0.31
- CATX 0.24
- MACD
- INGN 0.03
- CATX -0.01
- Stochastic Oscillator
- INGN 96.83
- CATX 26.15
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.